share_log

SVB Securities Adjusts Price Target on BridgeBio Pharma to $19 From $23, Maintains Outperform Rating

SVB Securities Adjusts Price Target on BridgeBio Pharma to $19 From $23, Maintains Outperform Rating

儲值支付工具證券調整盛生醫藥目標價格由 23 美元調整至 19 美元,維持「跑贏大市」評級
MT Newswires ·  2023/01/23 09:32

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論